Overview

Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The study is a comparison of twice-daily insulin lispro low mixture versus once-daily basal insulin glargine and once-daily prandial insulin lispro, in participants with Type 2 Diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc
Protamines